Navigation Links
Many prostate cancer patients receive improper or 'mismatched' therapies
Date:11/25/2007

Prostate cancer patients often receive treatment that is contraindicated by pre-existing conditions, like urinary or bowel dysfunction, according to a new study. Dr. James Talcott of the Massachusetts General Hospital in Boston and co-investigators found that patients with certain pretreatment dysfunctions often receive contraindicated or mismatched therapies, which can lead to worse outcomes. The study is published in the January 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

The American Cancer Society estimates that more than 218,000 American men are diagnosed with prostate cancer and more than 27,000 die from the disease each year. The three most common treatments for the disease are external beam radiation, brachytherapy, and radical prostatectomy.

Clinical studies have found no differences in efficacy among the three major therapies for the treatment of prostate cancer, but each brings with it certain risks, such as urinary incontinence or sexual dysfunction. Therefore, the best therapy for a particular patient will depend on the individuals pre-treatment status. For example, patients with pre-existing bowel dysfunction should not receive external beam radiation as a first line of therapy because the treatment inevitably irradiates the adjacent rectum in addition to the prostate and causes acute and long-term bowel dysfunction. Similarly, patients with problematic urinary obstructive symptoms should not receive brachytherapy, which delivers radiation to the prostate and can cause complete obstruction in patients with pre-existing obstructive symptoms.

Dr. Talcott and his colleagues surveyed 438 patients who sought therapy for untreated, localized prostate cancer from several hospitals in the Boston area between June 1, 1994 and August 31, 2000. Several additional questionnaires were mailed to patients until 36 months after treatment, and medical records were reviewed.

The study shows that 389 patients reported pre-existing dysfunction, and more than one-third received mismatched treatments. Increasing clinical complexity of a patients condition had little effect on the likelihood of mismatched treatments. Patients who had a single baseline dysfunction that contraindicated one treatment were just as likely to be given a mismatched treatment as patients with weaker contraindications or patients for whom multiple treatments were contraindicated. As expected, mismatched brachytherapy and external beam radiation therapy led to worsened urinary and bowel symptoms, respectively.

The investigators plan to test whether incorporating prostate cancerspecific survey instruments into clinical practice may increase awareness of patient baseline dysfunction, reduce treatment mismatches, and improve outcomes.

The authors conclude that their observations raise concerns about physician-patient communication. Similar situations may also exist for other types of cancer, producing unsuspecting barriers to patient-centered choices of treatment, palliative care and hospice, say the authors.


'/>"/>

Contact: Amy Molnar
amolnar@wiley.com
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Red wine compound shown to prevent prostate cancer
7. Barbershop Talks Cut Black Mens Prostate Cancer Risk
8. Generic prostate drug helps find high-risk cancers early
9. Finasteride unlikely to induce high grade prostate cancers
10. Shrinkage of prostate led to overestimation of cancer risk in trial
11. Prostate Cancer Awareness Week to Screen Thousands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... Caronlab Australia, an Australian ... January ECRM Trade Show in Hilton Head, SC, where it benefited from outstanding meetings ... quality of its beauty and wellness products. At this trade show, the company had ...
(Date:1/21/2017)... , ... January 21, 2017 , ... "ProDOF is the perfect set of tools for ... another subject in a scene," said Christina Austin - CEO of Pixel Film Studios. ... Easily create the illusion of a DSLR racking focus from one area into the ...
(Date:1/21/2017)... ... 2017 , ... Phytocéane invites you to take an exotic journey ... world with ZANZIBAR SHOWER GEL. Inspired by the beauty of Zanzibar, a Tanzanian archipelago ... moisturizing vegetal coral to create this gentle, crystal-clear shower gel to cleanse the body ...
(Date:1/21/2017)... CA (PRWEB) , ... January 21, 2017 , ... ... that Redwood Family Dermatology has recently joined their multi-specialty medical group. ... full range of cosmetic services. , “We’re excited to add this excellent dermatology ...
(Date:1/21/2017)... ... 2017 , ... In the United States, 20 million women and 10 million ... often feel shame for having struggled with an eating disorder as well as common ... Strong in Life After an Eating Disorder” -- to be featured at this year’s ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 /PRNewswire/ ... reach USD 233.7 billion by 2025, according to ... The market is anticipated to be predominantly driven ... companies, resulting into the large-scale production of new ... widen the influx of drugs at an unprecedented ...
(Date:1/19/2017)... Jan. 19, 2017 Report Details ... Alzheimer,s ... Leading Companies – our new study reveals trends, R&D ... and events affecting the Alzheimer,s disease therapeutics and diagnostics ... these key questions: - How is the Alzheimer,s disease ...
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
Breaking Medicine Technology: